Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,265
Closed -$3.36M 66
2025
Q3
$3.36M Buy
11,265
+161
+1% +$46.7K 0.02% 84
2025
Q2
$3.23M Hold
11,104
0.02% 83
2025
Q1
$3.41M Hold
11,104
0.03% 81
2024
Q4
$2.89M Sell
11,104
-1,344
-11% -$399K 0.02% 83
2024
Q3
$3.99M Sell
12,448
-146,091
-92% -$47.8M 0.03% 73
2024
Q2
$49.3M Buy
158,539
+3,450
+2% +$1.01M 0.28% 46
2024
Q1
$43.9M Buy
155,089
+50,224
+48% +$14.7M 0.25% 51
2023
Q4
$30.2M Buy
+104,865
New +$28.6M 0.19% 50

Other funds holding AMGN

APG Asset Management US's AMGN Position: Q4 2025 in Review

APG Asset Management US sold out of Amgen (AMGN) in Q4 2025, closing a stake of 11,265 shares — an estimated $3.36M sold.

APG Asset Management US first reported a position in AMGN in Q4 2023 and held it in 8 quarters. The position peaked at $49.3M in Q2 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • APG Asset Management US reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 11,265 Amgen shares in Q4 2025, an estimated $3.36M.
  • APG Asset Management US first reported a position in Amgen in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Amgen position peaked at $49.3M in Q2 2024.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.